ATE504205T1 - Methode zur bestimmung der immunogenität von proteinen, die eine veränderte immunantwort hervorrufen - Google Patents

Methode zur bestimmung der immunogenität von proteinen, die eine veränderte immunantwort hervorrufen

Info

Publication number
ATE504205T1
ATE504205T1 AT01986449T AT01986449T ATE504205T1 AT E504205 T1 ATE504205 T1 AT E504205T1 AT 01986449 T AT01986449 T AT 01986449T AT 01986449 T AT01986449 T AT 01986449T AT E504205 T1 ATE504205 T1 AT E504205T1
Authority
AT
Austria
Prior art keywords
produce
immunogenicity
proteins
determining
immune response
Prior art date
Application number
AT01986449T
Other languages
English (en)
Inventor
David Estell
Fiona Harding
Original Assignee
Danisco Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/677,822 external-priority patent/US6936249B1/en
Application filed by Danisco Us Inc filed Critical Danisco Us Inc
Application granted granted Critical
Publication of ATE504205T1 publication Critical patent/ATE504205T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
AT01986449T 2000-10-02 2001-09-26 Methode zur bestimmung der immunogenität von proteinen, die eine veränderte immunantwort hervorrufen ATE504205T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/677,822 US6936249B1 (en) 1998-04-15 2000-10-02 Proteins producing an altered immunogenic response and methods of making and using the same
US09/768,080 US6897049B1 (en) 1998-04-15 2001-01-23 Proteins producing an altered immunogenic response and methods of making and using the same
PCT/US2001/030062 WO2002040997A2 (en) 2000-10-02 2001-09-26 Production and use of proteins producing an altered immunogenic response

Publications (1)

Publication Number Publication Date
ATE504205T1 true ATE504205T1 (de) 2011-04-15

Family

ID=27101907

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01986449T ATE504205T1 (de) 2000-10-02 2001-09-26 Methode zur bestimmung der immunogenität von proteinen, die eine veränderte immunantwort hervorrufen

Country Status (7)

Country Link
EP (1) EP1469721B1 (de)
JP (1) JP5126761B2 (de)
AT (1) ATE504205T1 (de)
AU (1) AU2002237646A1 (de)
CA (1) CA2424720C (de)
DE (1) DE60144399D1 (de)
WO (1) WO2002040997A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE527276T1 (de) 2001-03-23 2011-10-15 Genencor Int Proteine, die veränderte immunogene reaktionen bewirken, und verfahren zu deren herstellung und anwendung
AU2003273679A1 (en) * 2002-06-11 2003-12-22 Merck Patent Gmbh Method for mapping and eliminating t-cell epitopes
US20080220450A1 (en) * 2004-04-26 2008-09-11 Danisco Us, Inc., Genencor Division Population Based Prediction Methods for Immune Response Determinations and Methods for Verifying Immunological Response Data
RU2011123911A (ru) * 2008-11-11 2012-12-20 ДАНИСКО ЮЭс ИНК. Композиции, содержащие варианты сериновых протеаз, и способы
CN102064161B (zh) * 2010-11-12 2013-09-04 嘉兴斯达微电子有限公司 一种优化的智能功率模块的功率封装结构
GB2499180A (en) * 2011-09-08 2013-08-14 Alcyomics Ltd Method of identifying sensitizers or allergens using measurements of T-cell proliferation and/or IFN Gamma
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760025A (en) 1984-05-29 1988-07-26 Genencor, Inc. Modified enzymes and methods for making same
SG30639G (en) 1986-04-30 1995-09-01 Genencor Int Non-human carbonyl hydrolase mutants DNA sequences and vectors encoding same and hosts transformed with said vectors
US5470560A (en) * 1987-01-20 1995-11-28 Genentech, Inc. Method for evaluating immunogenicity
AU9052891A (en) * 1990-12-05 1992-07-08 Novo Nordisk A/S Proteins with changed epitopes and methods for the production thereof
WO1999006061A1 (en) * 1997-07-29 1999-02-11 The Administrators Of The Tulane Educational Fund Prediction, detection, and design of t cell epitopes
US6642011B2 (en) * 1998-04-15 2003-11-04 Genencor International, Inc. Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
WO2000034317A2 (en) * 1998-12-08 2000-06-15 Biovation Limited Method for reducing immunogenicity of proteins

Also Published As

Publication number Publication date
JP5126761B2 (ja) 2013-01-23
WO2002040997A2 (en) 2002-05-23
DE60144399D1 (de) 2011-05-19
AU2002237646A1 (en) 2002-05-27
CA2424720A1 (en) 2002-05-23
JP2004528013A (ja) 2004-09-16
CA2424720C (en) 2012-04-03
WO2002040997A3 (en) 2004-08-12
EP1469721A2 (de) 2004-10-27
EP1469721B1 (de) 2011-04-06
WO2002040997A9 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
HUP0303753A2 (hu) Fúziós fehérjék immunogenitásának csökkentése
CY1119106T1 (el) Αντισωματα εναντι masp-2
ATE430207T1 (de) Genomische sequenzen von neisseria und verfahren zu ihrer verwendung
ATE418340T1 (de) Zusammensetzungen und methoden zur identifikation von antigenen, die eine immunantwort hervorrufen
MXPA01003557A (es) Secuencias genomicas de neisseria y metodos para su uso.
WO2001059130A3 (en) Proteins producing an altered immunogenic response and methods of making and using the same
CY1110180T1 (el) Μεθοδος για τον καθαρισμο ή την παραγωγη μιας mage πρωτεϊνης
DK1373296T3 (da) Proteiner, der frembringer et ændret immunogent respons, og fremgangsmåder til fremstilling og anvendelse deraf
DE69833755D1 (de) Verfahren zur herstellung von nicht-immunogenen proteinen
HUP0303173A2 (hu) Csökkent immunogenitású, módosított anti-EGFR-ellenanyagok
DK1645631T3 (da) Neisseria antigener og præparater
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
ATE439380T1 (de) Methoden zur herstellung humaner monoklonaler antikörper
EA200701911A1 (ru) Химерные рекомбинантные антигены toxoplasma gondii
DK1530637T3 (da) Carlsberg-subtilisin-proteiner med nedsat immunogenitet
ATE504205T1 (de) Methode zur bestimmung der immunogenität von proteinen, die eine veränderte immunantwort hervorrufen
ATE321850T1 (de) Verfahren zur herstellung von polynucleotivarianten
WO2000012535A3 (en) Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
DE60222296D1 (de) Impfstoff von umhüllten viren und verfahren zu seiner herstellung
DK46988D0 (da) Fremgangsmaade til fremstilling af katteleukaemivirusantigener og anvendelsen heraf
WO2002000250A3 (en) Hiv-1 vaccines and screening methods therefor
BR0316722A (pt) Constructos genéticos e composições compreendendo rre e cte e usos destes
DE60126490D1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1469721

Country of ref document: EP